Drug intelligence / Profile preview

Sonaliv

Development stage: Unknown
Lead developer: Sarian Healthcare
Modality: Small Molecules
Administration: Oral

Overview

Sonaliv is a branded generic liver tonic developed and marketed by Skyways Healthcare. It is part of the company's portfolio of pharmaceutical formulations distributed through the PCD (Propaganda Cum Distribution) franchise model in India. The product is indicated for the support of liver health and the management of hepatic disorders. While the specific chemical or herbal composition is not detailed in the company's high-level pipeline overview, such tonics generally function as hepatoprotective agents, aiding in the detoxification process and supporting the regeneration of liver parenchyma.

Brand names: Sonaliv

Beyond the preview

Go deeper on Sonaliv.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sonaliv.

Explore the full profile